Ximbio is the world’s largest non-profit reagent technology transfer service with an online portfolio of diverse and unique research reagents sourced globally. Scientists can exchange knowledge and maximise commercial opportunities for research reagents they have created. Our mission is to make these novel reagents easily available to scientists to accelerate life science research.
Ximbio is dedicated exclusively to life science research reagents of all kinds including antibodies, cell lines, mouse models and small molecules. These reagents are the cornerstones of basic scientific research that scientists can use to test their hypotheses, validate their ideas or develop new concepts. Ximbio provides a service for inventors, suppliers and users of novel reagents which contributes to our primary mission of advancing scientific research.
- Researchers and technology transfer offices can upload their reagents to the Ximbio website. Each reagent can be linked to the originating inventor, enabling scientists and institutions to raise the profile of their research.
- Life science companies use Ximbio to easily source new products for their portfolios via a straightforward commercialisation process.
- Bench scientists can make informed decisions about which reagents to use, though the Ximbio searchable database, extensive datasheets, peer reviews and supplier options.
Ximbio raises the profile of research reagents with scientists, allows inventors to deposit them and enables sharing with the life science community. Most of these products are created through funds from the public purse; be it government or charitable donations. We believe passionately in maximising the impact by-products of research and as such Ximbio broadens the range of tools available globally. We are committed to support and advance life science research.
Ximbio originates from Cancer Research UK. Ximbio is operated as a business unit of CRUK, and focuses on all areas of biology.
“We have created Ximbio to be a place where scientists and Technology Transfer Offices can share their research, and reagents companies can source new products, in a streamlined process that saves both time and resource, maximising the visibility and impact of all research reagents. By unifying the reagent community in this way, to make tools more widely and easily available, we hope to accelerate life science research.”
Bob Bondaryk, Head of Ximbio